GENES: STRUCTURE AND REGULATION
A Synergy Control Motif within the Attenuator Domain of CCAAT/Enhancer-binding Protein α Inhibits Transcriptional Synergy through Its PIASy-enhanced Modification by SUMO-1 or SUMO-3*

https://doi.org/10.1074/jbc.M210440200Get rights and content
Under a Creative Commons license
open access

One of the most common forms of functional interaction among transcription factors is the more than additive effect at promoters harboring multiple copies of a response element. The mechanisms that enable or control synergy at such compound response elements are poorly understood. We recently defined a common motif within the negative regulatory regions of multiple factors that operates by regulating their transcriptional synergy. We have identified such a synergy control (SC) motif embedded within the “attenuator domain” of CCAAT/enhancer-binding protein α (C/EBPα), a key regulator of energy homeostasis and cellular differentiation. A Lys159 → Arg substitution within the SC motif does not alter C/EBPα activity from a single site but leads to enhanced transactivation from synthetic or natural compound response elements. The sequence of SC motifs overlaps with the recently defined consensus SUMO modification site, and we find that the SC motif is the major site of both SUMO-1 and SUMO-3 modification in C/EBPα. Furthermore, the disruption of SC motif function is accompanied by loss of SUMO but not ubiquitin modification. C/EBPα interacts directly with the E2 SUMO-conjugating enzyme Ubc9 and can be SUMOylated in vitro using purified recombinant components. Notably, we find that PIASy has E3-like activity and enhances both SUMO-1 and SUMO-3 modification of C/EBPα in vivo and in vitro. Our results indicate that SUMO modification of SC motifs provides a means to rapidly control higher order interactions among transcription factors and suggests that SUMOylation may be a general mechanism to limit transcriptional synergy.

Cited by (0)

Published, JBC Papers in Press, January 2, 2003, DOI 10.1074/jbc.M210440200

*

This work was supported by United States Public Health Service Grant DK61656-01, American Heart Association (AHA) Scientist Development Grant AHA0130559Z, AHA postdoctoral fellowship AHA 0225755Z (to L. S.), and National Institutes of Health Grant MSTP TG GM 07863 (to M. D. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.